This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Statement From Jackel International

CRAMLINGTON, England, May 15, 2013 /PRNewswire/ --



Jackel International announces its response to Luv n'care, Ltd.'s latest lawsuit.

Jackel has reviewed the recent filing by Luv n' care and believes it is meritless, and nothing more than an attempt to interfere with Jackel's relationships with retailers. 

The Explora® line of products has patented technology which means it cannot be a copy of any Luv n' care product.

The lawsuit focuses on products that have been on sale since 2009 and which Luv n' care made no complaint about in its recent lawsuit against Jackel.  In fact Jackel has been innovating the tommee tippee® brand in this category for over 50 years, from the launch of the original tippee cup in the early 60s, and has enjoyed significant success through numerous innovations in the hard top cup category - all of which pre dates the contractual relationship Jackel International used to share with Luv n' care.

Steve Parkin, CEO of Jackel International, said: "If Luv n' care sincerely believed the Explora® line of products violated Luv n' care's contract rights, why didn't it put them in front of the jury in the first lawsuit?"

He continued: "Luv n' care has a history of litigation and this is just one more attempt to demerit the name of a competitor. We are confident that our customers will see this for what it is. We will be defending this lawsuit vigorously."

With regard to the previous case, Jackel International will be appealing the verdict made in February. It should also be pointed out that Luv n' care was only awarded less than half of the amount it claimed. Furthermore, it would only receive this if it wins the appeal.

Parkin concluded: "tommee tippee® is one of the most trusted and recognisable baby brands in the world, loved by millions of babies and recommended by generations of parents. We have a long history of winning awards that support our approach to world class innovation, product performance and design and are immensely proud of our reputation and award-winning products.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs